Dean Mitchell

Dean Jonathan Mitchell is currently Independent Chairman at Praxis Precision Medicines, Inc. since 2020 and Lead Independent Director at Theravance Biopharma, Inc. since 2014.
Former roles include President, Chief Executive Officer & Director at Guilford Pharmaceuticals, Inc. (2004-2005), President, Chief Executive Officer & Director at Zoetis Products LLC (2006-2008), President, Chief Executive Officer & Director at Lux Biosciences, Inc. (2010-2013), President & Chief Executive Officer at Alpharma LLC (2006-2008), Chairman at Emergent Travel Health, Inc. (2016-2018), Chairman at National Pharmaceutical Council, Chairman at Covis Pharma Holdings BV (2013-2020), Executive Chairman at Covis Pharma Holdings SARL (2013-2020), Chairman at Paxvax Corp.
(2016-2018), Chairman at Kinnate Biopharma, Inc. (2020-2024), Independent Director at ImmunoGen, Inc. (2012-2024), Non-Executive Director at MGI PHARMA, Inc. (2005-2008), Independent Director at ISTA Pharmaceuticals, Inc. (2004-2012), Director at Talecris Biotherapeutics Holdings Corp., Independent Director at Precigen, Inc. (2009-2024), President-International Pharmaceuticals at Bristol Myers Squibb Co. (2001-2004), Senior VP-Clinical Development & Product Strategy at GSK Plc (1999-2001), and President at MGI GP, Inc. (2005-2006).
Education includes an undergraduate degree from Coventry University and an MBA from Bayes Business School.